Yasemin Akkoyunlu
Iğdır University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yasemin Akkoyunlu.
Wiener Klinische Wochenschrift | 2013
Bahadir Ceylan; Bilgul Mete; Muzaffer Fincanci; Turan Aslan; Yasemin Akkoyunlu; Nail Ozgunes; Onur Colak; Alper Gunduz; Ebubekir Senates; Resat Ozaras; Ayşe İnci; Fehmi Tabak
SummaryBackgroundWe aimed to investigate whether mean platelet volume (MPV) and platelet distribution width (PDW) are variables determining the severity of liver fibrosis in patients with chronic HBV infection.MethodsPatients were divided into two groups with fibrosis scores of 0–2 and 3–6 (according to Ishac scoring system). Whether MPV and PDW were independent variables determining the severity of liver fibrosis score or not was investigated by comparing these groups.ResultsOf the 111 cases, 74 (66.7 %) were male (mean age 37.7 ± 11.6 years). Twenty-two of the cases (19.8 %) were HBeAg-positive. Fibrosis scores of 42 cases (37.8 %) were ≥ 3 and the remaining 69 cases had fibrosis scores < 3 (62.2 %). Independent variables determining the severity of fibrosis score were low levels of albumin and mean platelet volume, and high levels of prothrombin time and PDW (Odds ratio (95 % confidence interval) and p values were 0.105 (0.018–0.605) and 0.012 for albumin, 0.402 (0.234–0.692) and 0.001 for mean platelet volume, 1.529 (1.183–1.975) and 0.001 for PDW, and 0.924 (0.875–0.976) and 0.005 for prothrombin time, respectively). The sensitivity, specificity, positive predictive value and negative predictive value of regression model that is established using above mentioned parameters were 88.1, 75.3, 68.5, and 91.7 %, respectively (AUC = 0.886, p = 0.0001).ConclusionsMPV and PDW are independent variables determining the severity of liver fibrosis, and the regression model that is established using these parameters along with other markers, may give more information about the severity of liver fibrosis.ZusammenfassungHintergrundWir untersuchten, ob das mittlere Thrombozytenvolumen und die Verteilung der Thrombozytenbreite Variable sind, die den Schweregrad der Leberfibrose bei Patienten mit chronischer Hepatitis B (HBV) Infektion bestimmen.MethodenDie Patienten (n = 111, davon waren 74 (66,7 %) männlich, mittleres Alter: 37,7 ± 11,6 Jahre) wurden in 2 Gruppen je nach Fibrose Score (0–2 und 3–6) eingeteilt. Verwendet wurde das Ishac Score System. Ob das mittlere Thrombozytenvolumen und die Breitenverteilung der Thrombozyten unabhängige, den Schweregrad der Leberfibrose bestimmende Variable sind, wurde durch Vergleich dieser Gruppen geprüft.ErgebnisseZweiundzwanzig (19,8 %) Patienten waren HbeAg positiv. Die Fibrose Scores waren bei 42 Patienten (37,8 %) ≥ 3 und bei den restlichen 69 (62,2 %) Patienten < 3. Folgende Parameter stellten sich als unabhängige, den Schweregrad der Leberfibrose bestimmende Variable heraus: niedrige Albumin- und niedrige mittlere Thrombozytenvolumen-Werte, sowie hohe Werte der Prothromin Zeit und der Breite der Thrombozyten (Odds ratio (95 % Konfidenz Intervalle) und p Werte waren respektive: 0,105 (0,018–0,605) und 0,012 für Albumin, 0,402 (0,234–0,692) sowie 0,001 für das mittlere Thrombozytenvolumen, 1,529 (1,183–1,975) and 0,001 für die Verteilung der Thromzytenbreite, und 0,924 (0,875–0,976) and 0,005 für die Prothrombin Zeit). Die Sensitivität, Spezifität, der positive und der negative Vorhersagewert des Regressionsmodells, das unter Verwendung der oben erwähnten Parameter etabliert wurde waren: 88,1, 75,3, 68,5, and 91.7 %, respektive (AUC = 0,886, p = 0,0001).SchlussfolgerungenDas mittlere Thrombozytenvolumen und die Verteilung der Thrombozytenbreite sind unabhängige Variable, die den Schweregrad der Leberfibrose bestimmen. Das auf Basis dieser und anderer Parameter etablierte Regressionsmodell könnte mehr Information über den Schweregrad der Leberfibrose geben.
International Journal of Infectious Diseases | 2013
Bahadir Ceylan; Aylin Calıca; Oznur Ak; Yasemin Akkoyunlu; Vedat Turhan
Summary Crimean–Congo hemorrhagic fever (CCHF) is a viral infection associated with a high mortality rate. Ribavirin is the only drug used in the treatment of this disease. Studies investigating the effectiveness of ribavirin in CCHF have been retrospective and to date have included only a small number of cases. In recent years, due to climate changes, the number of cases of CCHF in Turkey has increased, and experience in the treatment of CCHF has improved. Several studies have evaluated the efficacy of ribavirin in Turkey, including one randomized controlled trial and two studies with a large number of cases. In these studies, ribavirin therapy was not shown to decrease mortality rates; the mortality rate was 2–9% in patients treated with ribavirin and 5.6–11% in those who were not treated with this drug. These findings suggest that patients with CCHF should be followed with supportive care only until randomized controlled trials with larger groups have been conducted.
Korean Journal of Laboratory Medicine | 2015
Meryem Iraz; Azer Ozad Duzgun; Cemal Sandalli; Mehmet Ziya Doymaz; Yasemin Akkoyunlu; Aysegul Saral; Anton Y. Peleg; Osman Birol Ozgumus; Fatih Şaban Beriş; Hakan Karaoglu; Ayşegül Çopur Çiçek
Background The emergence of carbapenem-resistant Klebsiella pneumoniae poses a serious problem to antibiotic management. We investigated the β-lactamases in a group of carbapenem-resistant K. pneumoniae clinical isolates from Turkey. Methods Thirty-seven strains of K. pneumoniae isolated from various clinical specimens were analyzed by antimicrobial susceptibility testing, PCR for the detection of β-lactamase genes, DNA sequencing, and repetitive extragenic palindronic (REP)-PCR analysis. Results All 37 isolates were resistant to ampicillin, ampicillin/sulbactam, piperacillin, piperacillin/tazobactam, ceftazidime, cefoperazone/sulbactam, cefepime, imipenem, and meropenem. The lowest resistance rates were observed for colistin (2.7%), tigecycline (11%), and amikacin (19%). According to PCR and sequencing results, 98% (36/37) of strains carried at least one carbapenemase gene, with 32 (86%) carrying OXA-48 and 7 (19%) carrying NDM-1. No other carbapenemase genes were identified. All strains carried a CTX-M-2-like β-lactamase, and some carried SHV- (97%), TEM- (9%), and CTX-M-1-like (62%) β-lactamases. Sequence analysis of blaTEM genes identified a blaTEM-166 with an amino acid change at position 53 (Arg53Gly) from blaTEM-1b, the first report of a mutation in this region. REP-PCR analysis revealed that there were seven different clonal groups, and temporo-spatial links were identified within these groups. Conclusions Combinations of β-lactamases were found in all strains, with the most common being OXA-48, SHV, TEM, and CTX-M-type (76% of strains). We have reported, for the first time, a high prevalence of the NDM-1 (19%) carbapenemase in carbapenem-resistant K. pneumoniae from Turkey. These enzymes often co-exist with other β-lactamases, such as TEM, SHV, and CTX-M β-lactamases.
Clinical Microbiology and Infection | 2015
Nese Saltoglu; Mucahit Yemisen; Onder Ergonul; Ayten Kadanali; Gül Karagöz; Ayse Batirel; Oznur Ak; Haluk Eraksoy; Atahan Cagatay; A. Vatan; Gonul Sengoz; Filiz Pehlivanoglu; Turan Aslan; Yasemin Akkoyunlu; Derya Ozturk Engin; Nurgul Ceran; B. Erturk; Lutfiye Mulazimoglu; Oral Oncul; Hakan Ay; Fatma Sargin; Nail Ozgunes; Funda Simsek; Taner Yildirmak; Nazan Tuna; Oguz Karabay; Kadriye Kart Yasar; Nuray Uzun; Yasar Kucukardali; M. Sonmezoglu
We aimed to investigate the predictors for limb loss among patients with diabetes who have complicated skin/soft-tissue infections. In this observational study, consecutive patients with diabetic foot infection (DFI) from 17 centres in Turkey, between May 2011 and May 2013 were included. The Turkish DFI Working Group performed the study. Predictors of limb loss were investigated by multivariate analysis. In total, 455 patients with DFI were included. Median age was 61 years, 68% were male, 65% of the patients were hospitalized, 52% of the patients had used antibiotics within the last month, and 121 (27%) had osteomyelitis. Of the 208 microorganisms isolated, 92 (44.2%) were Gram-positive cocci and 114 (54.8%) were Gram-negative rods (GNR). The most common GNR was Pseudomonas; the second was Escherichia coli, with extended spectrum β-lactamase positivity of 33%. Methicillin-resistant Staphylococcus species were found in 14% (29/208). Amputations were performed in 126/455 (28%) patients, 44/126 (34%) of these were major amputations. In multivariate analysis, significant predictors for limb loss were, male gender (OR 1.75, 95% CI 1.04-2.96, p 0.034), duration of diabetes >20 years (OR 1.9, 95% CI 1.18-3.11, p 0.008), infected ulcer versus cellulitis (OR 1.9, 95% CI 1.11-3.18, p 0.019), history of peripheral vascular disease (OR 2, 95% CI 1.26-3.27, p 0.004), retinopathy (OR 2.25, 95% CI 1.19-4.25, p 0.012), erythrocyte sedimentation rate >70 mm/hr (OR 1.6, 95% CI 1.01-2.68, p 0.05), and infection with GNR (OR 1.8, 95% CI 1.08-3.02, p 0.02). Multivariate analysis revealed that, besides the known risk factors such as male gender, duration of diabetes >20 years, infected ulcers, history of peripheral vascular disease and retinopathy, detection of GNR was a significant predictor of limb loss.
Wiener Klinische Wochenschrift | 2016
Bahadir Ceylan; Turan Aslan; Ahmet Çınar; Ayşe Ruhkar Kurt; Yasemin Akkoyunlu
SummaryBackgroundWe examined the changes of mean platelet volume (MPV) and platelet distribution width (PDW) in subjects with appendicitis and whether MPV and PDW could be used to predict the development of complication due to appendicitis.MethodsThe healthy control group, the cases of appendicitis with perforation, and the cases of appendicitis without perforation were compared with regard to MPV and PDW. We determined whether MPV and PDW were independent variables predictive of the development of complication in subjects with appendicitis.ResultsThis retrospective case-control study included a total of 362 patients (249 of which were male (68.8 %) and 113 were female (31.2 %); median age, 30 [range, 18–84 years]). One hundred and ninety-two subjects (53 %) presented with appendicitis and 170 (47 %) comprised the healthy control group. Sixty-six (18.2 %) of the subjects with appendicitis developed complication. MPVs were lower in subjects of appendicitis without complication compared to the subjects of appendicitis with complication and the control group (MPV, 9.78 ± 0.99 vs. 10.20 ± 1.21 and 10.14 ± 1.03, respectively [p = 0.005]). The PDW levels were not different between the three groups. Independent variables predictive of the presence of complication included increased MPV and time from onset of symptoms to hospital presentation (odds ratio[confidence interval], p-value: 1.507[1.064–2.133], 0.021 and 18.887[5.139-69.410], 0.0001, respectively).ConclusionsOur findings suggested these, MPV values in cases of appendicitis without complication were lower than the cases with complication and healthy control and MPV is a predictor of the development of complication in subjects with appendicitis.
Wiener Klinische Wochenschrift | 2013
Yasemin Akkoyunlu; Gulhan Arvas; Tamer Ozsarı; İsmail Necati Hakyemez; Bulent Kaya; Turan Aslan
SummaryAimThe aim of this study was to search rubella prevalence and compare the results with national and international data.Materials and methodsThe presence of anti-rubella immunoglobulin G (IgG) and anti-rubella immunoglobulin M (IgM) antibodies were studied in the sera obtained from cases with fever in last week and applied to the Microbiology Laboratory in the period between February 2010 and December 2010. No clinical sign or symptom regarding rubella infection has been evaluated for cases to obtain blood samples. IgM and IgG antibodies were tested with ELISA (Vitros ECI Q (J&J) Company Ortho Clinical Diagnostic Macro) method. The data obtained were assessed with SPSS statistical package using chi-square trend analysis method.ResultsAnti-rubella IgM positivity was found 8/68 (8.8 %) of males and 3/138 (2.2 %) of females who are under 18 years-old (p = 0.028). Meanwhile 47/65 (72.3 %) of males and 99/122 (81.8 %) of females under 18 years-old were presented with anti-rubella IgG positivity (p = 0.164). In all, 2/8 (25 %) males and 28/1,181 (2.4 %) females older than 18 years-old were anti-rubella IgM positive (p = 0.013). Anti-rubella IgG antibodies were found positive in 862/1,181 (73 %) of females and all males (8/8) older than 18-years-old (p = 0.086).ConclusionIn spite of the active immunization programme commenced after 2006, rubella infection is still a risk in Turkey without discriminating the gender.ZusammenfassungZiel der StudieErhebung der regionalen Seroprävalenz und Vergleich mit nationalen und internationalen Daten.Material und MethodenIn der Zeit zwischen Februar und Dezember 2010 wurden in an das mikrobiologische Labor eingesandten Sera von Patienten mit Fieber in der Woche vor der Abnahme auf das Vorliegen von Anti-Röteln IgG – und Anti-Röteln IgM Antikörper geprüft. Klinische Zeichen oder Symptome einer Röteln-Infektion wurden nicht erhoben. Die IgM und IgG Antikörper wurden mittels der ELISA Methode (Vitros ECI Q (J&J) Company Ortho Clinical Diagnostic Macro) getestet. Die Daten wurden mit Hilfe des SPSS statistical Package unter Verwendung der Chi-Quadrat Trend Analyse getestet.ErgebnisseIn 8/68 (8,8 %) Sera der Männer und in 3/138 (2,2 %) Sera der Frauen, die jünger als 18 Jahren waren konnten Anti Röteln-IgM-Antikörper nachgewiesen werden (p = 0,028). Anti-Röteln IgG Antikörper lagen dahingegen bei 47/65 (72,3 %) der Männer unter 18 und bei 99/122 (81,8 %) der Frauen unter 18 Jahren vor (p = 0,164). Bei den über 18 Jahre alten hatten zwei von acht (25 %) Männern und 28 von 1181 (2,4 %) Frauen nachweisbare Anti-Röteln IgM Antikörper (p = 0,013). Die IgG Anti-Röteln Antikörper waren bei 862 (73 %) der 1181 Frauen beziehungsweise bei allen Männern (8/8) positiv.SchlussfolgerungTrotz des seit 2006 existierenden aktiven Immunisierungsprogramms ist die Rötelninfektion in der Türkei noch immer ein Risiko, wobei dieses für Frauen und Männer gleich hoch ist.
International Journal of Infectious Diseases | 2018
Nese Saltoglu; Onder Ergonul; Necla Tulek; Mucahit Yemisen; Ayten Kadanali; Gül Karagöz; Ayse Batirel; Oznur Ak; Cagla Sonmezer; Haluk Eraksoy; Atahan Cagatay; Serkan Surme; Salih Atakan Nemli; Tuna Demirdal; Omer Coskun; Derya Ozturk; Nurgul Ceran; Filiz Pehlivanoglu; Gonul Sengoz; Turan Aslan; Yasemin Akkoyunlu; Oral Oncul; Hakan Ay; Lutfiye Mulazimoglu; Buket Erturk; Fatma Yilmaz; Gulsen Yoruk; Nuray Uzun; Funda Simsek; Taner Yildirmak
OBJECTIVES We described the clinical outcomes of the diabetic patients who had foot infections with multidrug resistant organisms. METHODS We included the patients with diabetic foot infections (DFI) from 19 centers, between May 2011 and December 2015. Infection was defined according to IDSA DFI guidelines. Patients with severe infection, complicated moderate infection were hospitalized. The patients were followed-up for 6 months after discharge. RESULTS In total, 791 patients with DFI were included, 531(67%) were male, median age was 62 (19-90). Severe infection was diagnosed in 85 (11%) patients. Osteomyelitis was diagnosed in 291(36.8%) patients. 536 microorganisms were isolated, the most common microorganisms were S. aureus (20%), P. aeruginosa (19%) and E. coli (12%). Methicillin resistance (MR) rate among Staphylococcus aureus isolates was 31%. Multidrug resistant bacteria were detected in 21% of P. aeruginosa isolates. ESBL (+) Gram negative bacteria (GNB) was detected in 38% of E. coli and Klebsiella isolates. Sixty three patients (8%) were re-hospitalized. Of the 791 patiens, 127 (16%) had major amputation, and 24 (3%) patients died. In multivariate analysis, significant predictors for fatality were; dialysis (OR: 8.3, CI: 1.82-38.15, p=0.006), isolation of Klebsiella spp. (OR:7.7, CI: 1.24-47.96, p=0.028), and chronic heart failure (OR: 3, CI: 1.01-9.04, p=0.05). MR Staphylococcus was detected in 21% of the rehospitalized patients, as the most common microorganism (p<0.001). CONCLUSION Among rehospitalized patients, methicillin resistant Staphylococcus infections was detected as the most common agent, and Klebsiella spp. infections were found to be significantly associated with fatality.
Brazilian Journal of Infectious Diseases | 2014
Yasemin Akkoyunlu; Bahadir Ceylan; Turan Aslan
A 43-year-old male patient was admitted to our clinic with fever and rash lasting for five days. His initial symptoms were sore throat, fever and rash on both hands and feet. He had been given ceftriaxone 2 g/day. Three days later no clinical improvement was observed and clindamycin 1200 mg/day was added to therapy. On admission, the patient had a body temperature of 37 ◦C, pulse 92 beats per minute, and blood pressure of 116/78 mmHg. On physical examination bilateral cryptic tonsillitis, rusty tongue and macular rashes on hands and feet were observed (Figs. 1–3). C reactive protein was 11.9 mg/dL, and erythrocyte sedimentation rate was 60 mm/h. The patient was on colchicine due to Behcet’s disease for 12 years. He had no fever on follow-up. Crypts on tonsils disappeared on the second day and vesicular rashes ensued on both tongue and labial mucosa. The patients’ IgM and IgG turned out positive for Coxsackie B virus by ELISA. Hand, foot, and mouth disease is known to be a childhood illness with fever and viral exanthema caused by species-A human enteroviruses (HEVA), genus Enterovirus, family Picornaviridae. Although it is rarely seen in adults, it must be considered in patients with fever of unknown origin.
Iranian Red Crescent Medical Journal | 2013
Yasemin Akkoyunlu; Bahadir Ceylan; Meryem Iraz; Nuh Mehmet Elmadag; Turan Aslan
Non typhoidal Salmonellae spp. causes clinical symptoms especially in neonates, infants, aged and immunocompromised patients. Hematogenous dissemination may occur in complicated cases whereas the formation of abscess is rare. A 61-year old woman presented to our hospital with pain and a mass in her left arm, without fever and leukocytosis. She was using methotrexate, corticosteroids and quinine for rheumatoid arthritis. She had a history of cervix cancer and was given radiotherapy and chemotherapy 3 years ago. Upon physical examination and magnetic resonance imaging, the mass was considered as an abscess and was surgically drained. Salmonella enterica spp. enterica was yielded in the culture of the drainage material. Ceftriaxon 2g/day was started intramuscularly and continued for 4 weeks. Salmonellosis is usually a self-limited disease, generally restricted to gastrointestinal tract and acquired following food poisoning. Management of Salmonella abscess requires a combination of antibiotherapy, surgical drainage and eradication of primary foci.
Asian Pacific Journal of Tropical Disease | 2012
Yasemin Akkoyunlu; Turan Aslan; Bahadir Ceylan; Bekir Inan; Cemalettin Aydin; Gulhan Arvas
Abstract Objective Aortic stent greft infections (ASGI) are associated with significant morbidity and mortality. ASGI may exist as a seldom cause of fever. Case report A 67 year-old male patient presented with fever, fatigue, chest pain and night sweats for a week. He had no infection sign except 3/6 systolic murmur. He admitted to the clinic with a prediagnosis of infective endocarditis. Combination therapy with ceftriaxon (2 g/day) + vancomycine (2 g/day) was administered. No vegetation was seen on neither transthoracic nor transesophageal ecocardiography. Methicillin-sensitive Staphylococcus aureus (MSSA) yielded in blood cultures. Antibiotherapy was changed to sulbactam-ampicilline (8 g/day). Then, we learned that the patient has an aortic stent placed due to aortic dissection. Contrast enhancement was detected in magnetic resonance imaging. Cardiovascular surgeons decided not to remove the stent because of increased mortality; therefore antimicrobial therapy was extended to 4 weeks. But soon after discharge from the hospital, the patient re-admitted with fever. Sulbactam-ampicilline was begun, and MSSA yielded in blood cultures again. Antibiotherapy was continued for an additional 6 weeks. No recurrent infection occurred during 6 months of follow-up. Conclusion ASGI could be one of the causes of fever of unknown origin (FUO). Despite the recommended treatment of ASGI being surgery, long-term conservative antimicrobial treatment may be performed successfully in patients with high surgical risk.